More recently, a study by Cardet et al. found that two RGS2 promoter variants that associate with decreased RGS2 expression associate with higher rates of asthma exacerbations among non-Hispanic White participants with moderate to severe asthma from the SARP3 cohort [60]. This evidence concerns the gene SFRP5 and asthma.